文献速递艾滋病与性传播感染病毒性肝炎

接受治疗的人类免疫缺陷病毒(HIV)感染者中肝脏炎症常见并与代谢紊乱相关

Liver Inflammation Is Common and Linked to Metabolic Derangements in Persons With Treated Human Immunodeficiency Virus (HIV).
PubMed 文献 · Clin Infect Dis · 2023-01-01

在无丙肝、乙肝及大量饮酒史的HIV感染者纵向观察队列中,662人纳入分析,中位随访4.0年期间67%出现至少1次、35%出现至少2次连续ALT升高。肝脏脂肪变性指数和西班牙裔/其他种族与ALT异常风险升高相关,提示非酒精性脂肪性肝病可能是接受抑制性抗逆转录病毒治疗者肝脏炎症的常见原因。

要点

  • 662例HIV感染者中,67%出现至少1次、35%出现至少2次连续ALT升高。
  • 肝脏脂肪变性指数(连续变量)与ALT异常风险升高相关,OR为1.1。
  • 西班牙裔/其他种族与ALT异常风险升高相关,OR为1.9-2.8。

核心结论

  • 在该HIV感染者队列中ALT升高常见,并与代谢性疾病及肝脏脂肪变性标志物相关。
  • 非酒精性脂肪性肝病可能是接受抑制性抗逆转录病毒治疗的HIV感染者肝脏炎症的常见原因,值得针对性诊断和干预。

研究设计与样本

  • 来自纵向观察性AIDS临床试验组HAILO队列的参与者,无丙肝病毒或乙肝病毒感染史且未报告大量饮酒。
  • 共纳入662名参与者,中位随访4.0年。
  • 比较有和无ALT升高参与者的临床和人口学特征,包括用药、肝脏脂肪变性指数(HSI)和代谢综合征(MetS)。

主要发现

  • 662名参与者中,444名(67%)出现至少1次连续ALT升高,229名(35%)出现至少2次连续ALT升高。
  • HSI(连续变量)与异常ALT的比值比(OR)为1.1。
  • 西班牙裔/其他(非白人或黑人)种族/族裔与至少1次或至少2次ALT升高的OR为1.9-2.8。
  • 年龄较大和当前吸烟与异常ALT的较低比值比相关。
  • 将结局限制为持续性和更高程度的ALT升高时,与代谢性疾病以及新发乙肝病毒和丙肝病毒感染的关联增强。

临床怎么用

  • 作者认为非酒精性脂肪性肝病可能是接受抑制性抗逆转录病毒治疗的HIV感染者肝脏炎症的常见原因,值得针对性诊断和干预。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We sought to characterize in people with human immunodeficiency virus (PWH) the potential etiologies of elevated alanine aminotransferase (ALT) levels, which are common and often unexplained. METHODS: Participants from the longitudinal observational AIDS Clinical Trials Group HAILO cohort without a history of hepatitis C virus (HCV) or hepatitis B virus (HBV) infection nor reported heavy alcohol use were included. Clinical and demographic characteristics, including medication use, the hepatic steatosis index (HSI), and metabolic syndrome (MetS) were compared between participants with and without ALT elevation. RESULTS: Six hundred sixty-two participants were included; 444 (67%) had ≥1 and 229 (35%) ≥2 consecutive ALT elevations during a median of 4.0 years of follow-up. HSI and Hispanic or other (non-White or Black) race/ethnicity were consistently associated with higher odds of abnormal ALT (odds ratio [OR] 1.1 for HSI as a continuous variable, OR 1.9-2.8 for Hispanic/other race/ethnicity for ≥1 or ≥2 ALT elevations); older age and current smoking were associated with lower odds of abnormal ALT. Associations with metabolic disease, as well as with incident HBV and HCV infection, were strengthened by restricting outcomes to persistent and higher degrees of ALT elevation. CONCLUSIONS: ALT elevation was common in this cohort of PWH and associated with metabolic disease and hepatic steatosis markers. Nonalcoholic fatty liver disease is likely a common cause of liver inflammation in PWH receiving suppressive antiretrovirals, deserving targeted diagnosis and intervention.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Chew KW, Wu K, Tassiopoulos K, et al. Liver Inflammation Is Common and Linked to Metabolic Derangements in Persons With Treated Human Immunodeficiency Virus (HIV). Clin Infect Dis. 2023. PMID: 36049028. doi:10.1093/cid/ciac708

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。